NQO1 and urogenital neoplasm: The inhibitors of NQO1 have shown promising outcomes in certain aspects where dicoumarol, a competitive inhibitor of NQO1, potentiates cisplatin-induced apoptosis in p53 wild-type urogenital cancer cell lines [24].